 for an AAA
Biomarkers for the presence and expansion of an
aortic aneurysm. The identiﬁcation of circulating
biomarkers for AAA disease remains an area of active
investigation. Such markers may assist in identifying
new targets for pharmacotherapy and may improve
both the diagnosis of AAA disease and monitoring of
the response to medical or surgical therapy. Among
biomarkers evaluated to date, ﬁbrinogen, D-dimer, and
